Medical Exoskeleton Market Size & Analysis | Report 202, 2027

The medical exoskeleton market was valued at US$ 96,783.1 thousand in 2018 and it is projected to reach US$ 1,023,036.8 thousand in 2027; it is expected to grow at a CAGR of 29.4% from 2019 to 2027.

Exoskeletons are used to enhance the physical strength of the human by assisting the limb movements with extra strength. The medical exoskeletons improve the quality of life of the physically disabled people such as patient with spinal cord injury, neurological disorder, paralysis or old age people. Some of the medical human exoskeletons are used by physiotherapy centers and rehabilitation centers, for lower and upper extremity treatment. The growth of the global medical exoskeleton market is attributed to the increase in the number of orthopaedic surgeries, rise in the geriatric population and growing incidences of road accidents. However, high cost of the product and regulatory concerns is the major factor hindering the market growth.

The global medical exoskeleton market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Global Medical Exoskeleton Market

Get more information on this report : Request Free Sample PDF

Market Insights

Increase In The Number of Orthopaedic Surgeries to Drive Global Medical Exoskeleton Market Growth

The rise in orthopedic surgeries is majorly driven by the operations done for the replacements of the knee and hip joints. The surgeries have been done for the amputations of limbs due to the increasing rate of damages or injuries caused by road accidents or various diseases. The rising number of operations for amputation are observed for patients who have diabetes and also have developed a condition of gangrene. For instance, according to the U.S. Agency for Healthcare Research and Quality, in the United States, approximately replacement surgeries are performed per year. For the deteriorating joints, the knee replacement surgeries have performed in the geriatric population.

Knee replacement is among the most commonly performed orthopedic procedures. The number of surgeries is increasing due to the rising chronic conditions, including rheumatoid arthritis (RA), ankylosing spondylitis (AS) and osteoporosis. For instance, according to a report published in 2018 of Healthline Media, rheumatoid arthritis (RA) affects 41 in every 100,000 people per year, and near round, 1.3 million Americans have RA. Likewise, data published by the Spondylitis Association of America, states that in America, spondyloarthritis is found in approximately in 2.7million people, which is 1 in 100 population. Similarly, according to the International Osteoporosis Foundation, osteoporosis is estimated to affect 200 million women across the world, in 2018. Among which near around one-tenth of women are above the age of 60, one-fifth of women aged more than 70, two-fifths of women aged above 80 and two- thirds of women aged more than 90.

Moreover, the number of surgeries is expected to be rising to the musculoskeletal disorders that are associated with sports, occupational injuries, and age-related dysfunction. For instance, according to Arthritis Foundation, in 2017, approximately 54 million adults have been diagnosed with arthritis. Also, nearly 300,000 babies and children have arthritis or a rheumatic condition. Also, the standard type of arthritis diagnosed is osteoarthritis, which affects approximately 31 million Americans. Therefore, demand for the exoskeleton systems is increasing owing to providing strength and helps in maintaining the proper posture of the body. Thus, increasing rate of orthopedic surgeries is likely to drive the market for the medical exoskeleton in the coming years.

Drive Type -Based Insights

In terms of drive type, the global medical exoskeleton market is segmented into pneumatic actuator, hydraulic actuator, electric actuator, mechanical, shape memory alloy actuator and other actuators. In 2018, the electric actuator segment held largest share of the market and, the same segment is estimated to register the highest CAGR during the forecast period.

Global Medical Exoskeleton Market, by Drive Type – 2018 and 2027

Get more information on this report : Request Free Sample PDF

Type -Based Insights

Based on type, the global medical exoskeleton market is segmented into powered exoskeleton and passive exoskeleton. The powered exoskeleton segment held the largest market share in 2018. Also, the same segment is estimated to grow at the fastest rate during the forecast period.

Extremity-Based Insights

In terms of extremity, the global medical exoskeleton market is segmented into lower body exoskeleton and upper body exoskeleton. In 2018, the lower body exoskeleton segment held largest share of the market. The upper body exoskeleton segment is expected to register the highest CAGR during the forecast period

Application-Based Insights

In terms of application, the global medical exoskeleton market is segmented into spinal cord injury, multiple sclerosis, cerebral palsy, stroke and others. In 2018, the spinal cord injury segment held largest share of the market. Also, the same segment is expected to register the highest CAGR during the forecast period.

End User-Based Insights

In terms of end user, the global medical exoskeleton market is segmented into rehabilitation centers, physiotherapy centers, and others. The rehabilitation centers segment held the largest share of the market in 2018, and the same segment is estimated to grow at the fastest rate during the forecast period.

Strategic Insights

The global medical exoskeleton market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Global Medical Exoskeleton Market – by Drive Type

• Pneumatic Actuator
• Hydraulic Actuator
• Electric Actuator
• Mechanical
• Shape Memory Alloy Actuator
• Other Actuator

Global Medical Exoskeleton Market – by Type

• Powered Exoskeleton
• Passive Exoskeleton

Global Medical Exoskeleton Market – by Extremity

• Lower Body Exoskeleton
• Upper Body Exoskeleton

Global Medical Exoskeleton Market – by Application

• Spinal Cord Injury
• Multiple Sclerosis
• Cerebral Palsy
• Stroke
• Other

Global Medical Exoskeleton Market – by End- User

• Rehabilitation Centers
• Physiotherapy Centers
• Others

Global Medical Exoskeleton Market – by Geography

• North America

  • US
  • Canada
  • Mexico

• Europe

  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe

• Asia Pacific (APAC)

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of APAC

• Middle East & Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

• South America and Central America (SCAM)

  • Brazil
  • Argentina
  • Rest of SCAM

Company Profiles

• Bioness Inc.
• B-Temia Inc.
• BIONIK Laboratories Corp
• CYBERDYNE INC
• Ekso Bionics Holdings, Inc
• EXOATLET
• GOGOA Mobility Robots
• Hocoma AG
• Wearable Robotics srl
• Parker Hannifin Corporation
• ReWalk Robotics
• US Bionics, Inc.
• Tyromotion GmbH